logo
Select company
Select metric
75.1%Cash to Assets Ratio
VS
Market
96
Sector
86
Industry
79
History
38
$ 159.01Close
$ 4.5 - $ 182.6 52-Week Range
Ticker Information

Ticker

SPRB

Company Name

SPRUCE BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SPRUCE BIOSCIENCES INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SPRB - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 21.82M$ 16.39M75.1%
3/31/2025$ 31.65M$ 25.61M80.93%
12/31/2024$ 45.21M$ 38.75M85.72%
9/30/2024$ 65.1M$ 60.05M92.25%
6/30/2024$ 75.52M$ 69.68M92.27%
3/31/2024$ 87.54M$ 81.15M92.71%
12/31/2023$ 103.95M$ 96.34M92.68%
9/30/2023$ 112.98M$ 98.8M87.45%
6/30/2023$ 125.96M$ 97.48M77.39%
3/31/2023$ 139.11M$ 73.93M53.14%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SPRUCE BIOSCIENCES INC's latest trailing twelve months (TTM) Cash to Assets stands at 92.21%.
  • Over the past 5 years, SPRUCE BIOSCIENCES INC's average Cash to Assets has been 68.23%.
  • The median Cash to Assets for SPRUCE BIOSCIENCES INC during this period was 79.16%
  • SPRUCE BIOSCIENCES INC reached its highest Cash to Assets over the past 5 years at 96.66%.
  • The lowest Cash to Assets recorded by SPRUCE BIOSCIENCES INC in the same timeframe 20.49%

SPRUCE BIOSCIENCES INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
ONCO : ONCONETIX INC 1.48%SXTP : 60 DEGREES PHARMACEUTICALS INC 47.03%VIVS : VIVOSIM LABS INC 76.79%XBIO : XENETIC BIOSCIENCES INC 89.28%OGEN : ORAGENICS INC 92.24%ADTX : ADITXT INC 1.65%CDT : CONDUIT PHARMACEUTICALS INC 41.71%GTBP : GT BIOPHARMA INC 74.69%KTTA : PASITHEA THERAPEUTICS CORP 42.43%TCRT : ALAUNOS THERAPEUTICS INC 60.8%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for SPRUCE BIOSCIENCES INC is calculated as follows: CashnEq [ $ 72.37M ] / Assets [ $ 78.48M ]
(=) Cash to Assets [ 92.21% ]

SPRB - Cash to Assets Ratio, Last 5 years

20.49%

Minimum

Mar 31, 2022

96.66%

Maximum

Mar 31, 2021

68.23%

Average

79.16%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.76% with a standard deviation of 9.51%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.71%
average9.76%
median6.41%
std9.51%